A pilot study on self-induced trance after psychedelic therapy
Self-Induced Cognitive Trance (TCAI) as a therapeutic support after or during psychedelic therapy: a pilot study to strengthen patients’ autonomy in mental health.
An innovative scientific study to validate the effectiveness of self-induced trance after psychedelic therapies.
Today in Switzerland, psychedelic-assisted therapies offer real hope to people suffering from severe mental health disorders such as treatment-resistant depression, post-traumatic stress disorder (PTSD), or addictions. These therapies, delivered under special («compassionate use») authorization, are limited in time, very expensive (up to 800 CHF for the substance, plus the cost of a full-day session, at the patient’s expense), and patients can no longer legally continue these treatments once their authorization expires.
This project is unique because, for the first time, it proposes to evaluate whether Self-Induced Cognitive Trance (TCAI), an innovative practice that allows individuals to reach a similar altered state of consciousness without psychedelic substances, can be used. TCAI could thus offer patients a concrete, autonomous, and free way to prolong the therapeutic benefits after the end of official psychedelic treatments.
Your support will fund the concrete implementation of this pilot study on TCAI.
The funds raised will be used directly to finance the training of patients in Self-Induced Cognitive Trance (SICT), to compensate specialized trainers, to ensure rigorous scientific monitoring, and to publish the results of this innovative pilot study.
